Lucinda A. Harris, M.D.

  1. Gastroenterologist
  2. Internist

Location

  1. Phoenix, Arizona

Languages

English
  • Irritable bowel syndrome
  • Gastrointestinal motility disorders
  • Gastroesophageal reflux disease
  • Celiac disease (sprue)
  • Women's health issues in GI
  1. 1989
    Fellow - Department of Medicine - Division of Digestive DiseasesCornell University Medical College
  2. 1986
    Resident - Department of MedicineNew York Presbyterian Hospital, College of Physicians and Surgeons, Columbia University, New York, NY
  3. 1983
    MDUniversity of Connecticut School of Medicine
  4. 1979
    MS - Community HealthUniversity of Connecticut
  5. 1976
    BA - BiochemistryBarnard College

Awards and honors

  1. 2013
    Excellence in Clinical Practice Writer's AwardSociety of Gastroenterology Nurses and Associates, Inc.
  2. 1971
    Honors GroupWestinghouse Science Talent Search
  3.  
    Scholars in Medicine ProgramUniversity of Connecticut School of Medicine
  4.  
    American Medical Women's Association GrantAmerican Medical Women's Association

Professional memberships

  1. 2016 - present
    MemberSelection Committee, Internal Medicine Residency, Department of Internal Medicine
  2. 2015 - present
    ChairClinical Competency Committee, Gastroenterology Fellowship, Division of Gastroenterology
  3. 2013
    Co-DirectorMotility, Division of Gastroenterology, Department of Internal Medicine
  4. 2013 - present
    FellowAmerican Gastroenterological Association
  5. 2012
    ConsultantTakeda Pharmaceuticals
  6. 2009
    Co-DirectorMotility, Division of Gastroenterology, Department of Internal Medicine
  7. 2009
    ConsultantProcter & Gamble
  8. 2009
    ConsultantSalix Pharmaceuticals, Inc.
  9. 2009 - present
    MemberAmerican Society for Gastrointestinal Endoscopy
  10. 2008 - 2010
    ConsultantTakeda Pharmaceuticals
  11. 2008
    ConsultantPrometheus Laboratories
  12. 2008 - present
    ConsultantIronwood Pharmaceuticals
  13. 2007
    ReviewerFunctional Abstracts for October 2007 Meeting, American College of Gastroenterology
  14. 2007
    MemberWomen in Gastroenterology Committee, American College of Gastroenterology
  15. 2007 - present
    Advisory Board MemberInternational Foundation for Functional Gastrointestinal Disorders
  16. 2006 - 2008
    MemberGastrointestinal Events Research Board, Renzapride-Quintiles, Inc.
  17. 2006
    MemberSelection Committee for Chairman, Division of Gastroenterology, Department of Internal Medicine
  18. 2006 - present
    MemberEducation Committee, Gastroenterology Fellowship, Division of Gastroenterology
  19. 2006 - present
    MemberGastroenterology Task Force of the Mayo Pharmaceutical Formulary Committee, Division of Gastroenterology, Department of Internal Medicine
  20. 2006 - present
    Department Education CoordinatorDivision of Gastroenterology, Department of Internal Medicine
  21. 2006 - present
    MemberDigestive Center for Women Network
  22. 2005 - present
    MemberAmerican Motility Society
  23. 2004 - 2006
    Co-DirectorIrritable Bowel Syndrome Patient Support Group, Mayo Clinic Arizona Task Forces
  24. 2004 - 2006
    Co-DirectorIrritable Bowel Syndrome Patient Support Group, Division of Gastroenterology, Department of Internal Medicine
  25. 2004 - 2006
    MemberIrritable Bowel Syndrome Patient Support Group, Mayo Clinic Arizona Task Forces
  26. 2004 - present
    Co-AdvisorJournal Club, Division of Gastroenterology, Department of Internal Medicine
  27. 2004 - present
    MemberJournal Club, Division of Gastroenterology, Department of Internal Medicine
  28. 2003
    MemberAdvisory Board, American Pharmaceutical Association
  29. 2003
    MemberGastrointestinal Advisory Board on Irritable Bowel Syndrome, Solway Pharmaceutical Co.
  30. 2003
    MemberConsultancy Network - Zelnorm, Novartis Pharmaceuticals
  31. 2002
    MemberGastrointestinal Advisory Board - Alosetron, GlaxoSmithKline
  32. 2002 - 2003
    MemberGastrointestinal Advisory Board - Talnetant for Irritable Bowel Syndrome, GlaxoSmithKline
  33. 2002
    MemberGastrointestinal Advisory Board - Zelnorm Efficacy & Safety, Novartis Pharmaceuticals
  34. 2002
    MemberReintroduction of Lotronex, GlaxoSmithKline
  35. 2002 - present
    FellowAmerican College of Physicians
  36. 2002 - present
    MemberFunctional Brain-Gut Research Group
  37. 2001
    MemberGastrointestinal National Advisory Board, GlaxoSmithKline
  38. 2001
    MemberAdvisory Board on Cilansetron, Solway Pharmaceutical Co.
  39. 2001
    MemberGastrointestinal Advisory Board on Irritable Bowel Syndrome & Zelnorm, RuderFinn, Inc.
  40. 2001 - present
    MemberAmerican College of Gastroenterology
  41. 2001 - present
    MemberInternational Foundation for Functional Gastrointestinal Disorders
  42. 2000
    MemberLotronex to the FDA, Glaxo Wellcome, Inc.
  43. 2000 - 2001
    MemberIrritable Bowel Syndrome National Advisory Board, Glaxo Wellcome, Inc.
  44. 2000
    Group LeaderIrritable Bowel Syndrome Regional Advisory Board, Glaxo Wellcome, Inc.
  45. 2000
    MemberIrritable Bowel Syndrome National Advisory Board, Novartis Pharmaceuticals
  46. 2000
    MemberGlobal Telegenetics Medical Group
  47. 2000
    MemberLaunch of Lotronex Consultants Meeting, Glaxo Wellcome, Inc.
  48. 2000 - 2006
    EditorGastroenterology Section, praxismd.com (Website for physicians and patients) evolved to Micromedex
  49. 1999 - 2004
    MemberFormulary and Therapeutics Committee, New York Presbyterian Hospital
  50. 1999 - 2004
    MemberGerson Lehrman Financial Group
  51. 1999 - 2003
    MemberAmerican Liver Foundation
  52. 1999 - 2000
    MemberIrritable Bowel Syndrome Regional Advisory Board, Glaxo Wellcome, Inc.
  53. 1999
    ConsultantIrritable Bowel Syndrome Regional Advisory Board, Glaxo Wellcome, Inc.
  54. 1990 - present
    MemberCrohn's and Colitis Foundation of America
  55. 1989 - present
    MemberAmerican College of Physicians
  56. 1988 - present
    MemberNew York Society of Gastrointestinal Endoscopy
  57. 1987 - present
    MemberAmerican Gastroenterological Association
  58. 1979 - present
    MemberAmerican Medical Women's Association
  59.  
    FellowAmerican College of Gastroenterology
  60.  
    ConsultantIrritable Bowel Syndrome National Advisory Board, Novartis Pharmaceuticals
  61.  
    ConsultantIrritable Bowel Syndrome National Advisory Board, Glaxo Wellcome, Inc.
  62.  
    ConsultantGastrointestinal Advisory Board on Irritable Bowel Syndrome & Zelnorm, RuderFinn, Inc.
  63.  
    ConsultantGastrointestinal National Advisory Board, GlaxoSmithKline
  64.  
    ConsultantGastrointestinal Advisory Board - Alosetron, GlaxoSmithKline
  65.  
    ConsultantGastrointestinal Advisory Board - Zelnorm Efficacy & Safety, Novartis Pharmaceuticals
  66.  
    ConsultantReintroduction of Lotronex, GlaxoSmithKline
  67.  
    ConsultantGastrointestinal Advisory Board - Talnetant for Irritable Bowel Syndrome, GlaxoSmithKline
  68.  
    ConsultantGastrointestinal Advisory Board on Irritable Bowel Syndrome, Solway Pharmaceutical Co.
  69.  
    ConsultantGerson Lehrman Financial Group
  70.  
    ConsultantGastroenterology, Global Telegenetics Medical Group
  71.  
    Clinical ConsultantAdvisory Board on Cilansetron, Solway Pharmaceutical Co.
  72.  
    Clinical ConsultantLotronex to the FDA, Glaxo Wellcome, Inc.
  73.  
    ConsultantGastrointestinal Events Research Board, Renzapride-Quintiles, Inc.
  74.  
    MemberZelnorm, New Product Bulletin, Advisory Board

Publications